Role of cholinesterase inhibitors in dementia care needs rethinking

The NHS focus on memory clinics driven by drugs that slow cognitive decline is taking resources away from services offering long term integrated care. The role of these clinics needs reconsideration alongside availability of the drugs

Saved in:
Bibliographic Details
Published inBMJ Vol. 333; no. 7566; pp. 491 - 493
Main Authors Pelosi, Anthony J, McNulty, Seamus V, Jackson, Graham A
Format Journal Article
LanguageEnglish
Published England British Medical Journal Publishing Group 02.09.2006
BMJ Publishing Group LTD
BMJ Publishing Group Ltd
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The NHS focus on memory clinics driven by drugs that slow cognitive decline is taking resources away from services offering long term integrated care. The role of these clinics needs reconsideration alongside availability of the drugs
Bibliography:istex:42C2FB19ED6C2E7CE0CFDA365F293033020AEE36
ark:/67375/NVC-9RK42LGQ-X
href:bmj-333-491.pdf
PMID:16946340
Correspondence to: A J Pelosi
local:bmj;333/7566/491
ArticleID:bmj.38945.478160.94
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
References w1-w14 are on bmj.com
Correspondence to: A J Pelosi a.pelosi@clinmed.gla.ac.uk
We thank the referees for their helpful comments on an earlier draft.
Contributors and sources: GAJ, SVM, and AJP all have a particular interest in delivery of psychiatry services. This article is the end product of several years' discussion on this topic, and experience of dealing with patients with dementia within their services. All authors contributed to the ideas for this paper and to its writing and redrafting. AJP is the guarantor.
Competing interests: None declared.
ISSN:0959-8138
1468-5833
1756-1833
DOI:10.1136/bmj.38945.478160.94